Target intelligence / Profile preview

Calcium release-activated channel regulator 2B (CRACR2B)

Target
CRACR2B
Molecular classification
Ion channel regulator, Calcium-binding protein, Signaling adaptor
01

Overview

Calcium release-activated channel regulator 2B (CRACR2B) is a protein-coding gene that encodes a regulator protein involved in store-operated calcium entry (SOCE), an essential biological pathway for calcium influx in non-excitable cells. CRACR2B binds calcium ions and participates in the activation or modulation of CRAC channels, which replenish endoplasmic reticulum calcium stores and are vital for diverse cellular functions, including immune cell activation and gene expression[1][4][5]. Mutations or dysregulation in the SOCE pathway, including its regulators, are linked to disorders such as developmental and epileptic encephalopathies. Unlike the core CRAC channel pore-forming proteins (e.g., Orai1), CRACR2B acts as a regulator and is not itself the channel pore; it is essential for proper Ca2+ signaling and immune responses but has not been established as a direct pharmacological target to date[1].

Other names
CRACR2BEFC4AEF-hand calcium-binding domain-containing protein 4A
02

Mechanism of action

Store-operated calcium channel modulation (modifies SOCE pathway via regulation of CRAC channel activation) Not a primary drug target itself, but acts upstream/in concert with CRAC channel components

03

Biological functions

Regulation of store-operated calcium entry (SOCE)Calcium ion bindingModulation of intracellular calcium signaling
04

Disease associations

Developmental and epileptic encephalopathy 50ParagonimiasisImmune dysregulation (by analogy to the functions of store-operated calcium pathways[4][5])
05

Safety considerations

Not well characterized; disturbances in SOCE generally can impact immune function and neuronal signaling, but specific safety data for CRACR2B-targeted modulation are lacking
06

Interacting drugs

None directly described for CRACR2B, but inhibitors of SOCE/CRAC channels (such as BTP2/YM-58483) may indirectly affect CRACR2B function as part of the regulatory complex. The more established drug-target links are for the Orai/STIM channel complex rather than CRACR2B specifically.
07

Biomarkers

None currently established specific to CRACR2B for patient selection or monitoring

Beyond the preview

Go deeper on Calcium release-activated channel regulator 2B (CRACR2B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Calcium release-activated channel regulator 2B (CRACR2B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call